Literature DB >> 3422695

CA 125 and survival in ovarian cancer: preliminary communication.

D Parker1, K Patel, E J Alred, P Harnden-Mayor, B Naylor.   

Abstract

CA 125 is an epithelial membrane marker which can be detected in the serum of patients with ovarian cancer and which may reflect tumour burden. In a group of 42 patients, the level of this marker has also been shown to be significantly related to survival.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3422695      PMCID： PMC1291422          DOI： 10.1177/014107688808100110

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


  3 in total

1.  Risk and prognostic factors in trophoblastic neoplasia.

Authors:  K D Bagshawe
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

2.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

3.  Tumour-marker levels and prognosis in malignant teratoma of the testis.

Authors:  J R Germa-Lluch; R H Begent; K D Bagshawe
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640
  3 in total
  1 in total

1.  An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer.

Authors:  D J Cruickshank; J Paul; C R Lewis; E J McAllister; S B Kaye
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.